MRI-detected lesion of the breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) A patient who has an MRI-detected lesion in breast MRI examination 2) Female aged over 20 years old 3) Performance status 0-1 4) Agreement on informed consent for this clinical trial
Exclusion criteria
Exclusion criteria: 1) A patient with a pacemaker 2) A patient with allergy for a contrast medium for MRI 3) A patient with a metallic artificial heart valve 4) A patient with past asthmatic symptom 5) A patient with a severe renal dysfunction 6) A patient with a severe claustrophobia 7) A patient with a tattoo 8) A patient who needs follow-up with expander included magnet 9) A patient who is not able to perform breast MRI with some reasons 10) A patient who is not able to perform VAB 11) A patient who is pregnant or a patient who has a possibility of being pregnant 12) A patient who is lactating 13) A patient who has a history of mental disorder or central nervous disorder 14) A patients who is not considered suitable by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of tissue sampling by vacuum assisted biopsy using second-look US with RVS/Vnavi for MRI-detected lesion | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Sonographic detection rate of MRI-detected lesion using second-look US with RVS/Vnavi 2) Safety of RVS/Vnavi 3) Time to detect MRI-detected lesion using second-look US with RVS/Vnavi | — |
Countries
Japan
Contacts
Aichi Medical University Division of Breast and Endocrine Surgery, Department of Surgery